Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-04-30CDT3Limited Power of Attorney for SEC Reporting PurposesMEDIUM
This filing details a Limited Power of Attorney granted by Ulrik K. Olsen, a director of CDT Equity Inc., to James Bligh and others. This power of attorney authorizes the appointed individuals to act on Mr. Olsen's behalf for all SEC reporting requirements, including obtaining EDGAR credentials, managing the EDGAR acco...
Nano CapBiotechnology
2026-04-30PRTC3PureTech Entities File Form 3 for Seaport Therapeutics OwnershipMEDIUM
PureTech LYT, Inc., PureTech Health LLC, and PureTech Health plc have filed a Form 3 initial statement of beneficial ownership for Seaport Therapeutics, Inc. (SPTX). The filing reveals that PureTech LYT, Inc. holds 302,479 shares of common stock and convertible preferred stock that can convert into 15,420,534 additiona...
Small CapBiotechnology
2026-04-30PureTech Health plc3PureTech Entities File Form 3 for Seaport Therapeutics OwnershipDuplicateMEDIUM
PureTech LYT, Inc., PureTech Health LLC, and PureTech Health plc have filed a Form 3 initial statement of beneficial ownership for Seaport Therapeutics, Inc. (SPTX). The filing reveals that PureTech LYT, Inc. holds 302,479 shares of common stock and convertible preferred stock that can convert into 15,420,534 additiona...
Small CapBiotechnology
2026-04-30PureTech Health plc3PureTech Entities File Form 3 for Seaport Therapeutics OwnershipDuplicateMEDIUM
PureTech LYT, Inc., PureTech Health LLC, and PureTech Health plc have filed a Form 3 initial statement of beneficial ownership for Seaport Therapeutics, Inc. (SPTX). The filing reveals that PureTech LYT, Inc. holds 302,479 shares of common stock and convertible preferred stock that can convert into 15,420,534 additiona...
Small CapBiotechnology
2026-04-30LXEO3Lexeo Therapeutics, Inc. - Form 3 Filing and Power of AttorneyMEDIUM
This filing includes a Form 3, which reports initial beneficial ownership of securities, for Laura Sepp-Lorenzino, a director at Lexeo Therapeutics, Inc. The filing also includes a Limited Power of Attorney, dated April 27, 2026, appointing Youjin Choi, Carole Rosenberg, and James Reilly as attorneys-in-fact. These att...
Small CapBiotechnology
2026-04-29ATHE3ALTERITY THERAPEUTICS LTD - Form 3 Filing
This filing is an initial statement of beneficial ownership of securities filed by Ann Michelle Cunningham, a director at ALTERITY THERAPEUTICS LTD. The report indicates that Ms. Cunningham has no securities owned as of the period of report, April 17, 2026. The filing is made in accordance with SEC regulations for repo...
Micro CapBiotechnology
2026-04-29ANL3Insider Transaction Report for Ji Ping
This filing is an initial report of beneficial ownership for Ji Ping, a director at Adlai Nortye Ltd. (ANL). The report, designated as Form 3, indicates that Ji Ping acquired no new securities and currently holds no direct or indirect beneficial ownership of the company's securities as of March 18, 2026. The reporting ...
Small CapBiotechnology
Sponsored